BrUOG 355: Nivolumab to Tailored Radiation Therapy With Concomitant Cisplatin in the Treatment of Patients With Cervical Cancer

NCT03527264 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Slow enrollment

Conditions

Cervical Cancer

Interventions

DRUG: Nivolumab induction
DRUG: Cisplatin
RADIATION: Radiation
DRUG: Nivolumab with chemoradiation
DRUG: Nivolumab maintenance

Sponsor

Brown University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]